Patient Care

iCAD and Windsong Radiology Announce Strategic Commercial Agreement to Implement AI-Powered Mammography

Windsong Radiology to Champion First Wave of ProFound AI Breast Health Suite ExpansionNASHUA, N.H. and WILLIAMSVILLE, N.Y. and RALEIGH, N.C.,…

5 months ago

AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics

EYSINS, Switzerland, July 29, 2024 /PRNewswire/ -- AliveDx ("Company") is proud to announce it has received IVDR CE mark for…

5 months ago

BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo

July 26, 2024 News Release BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo ADLM…

5 months ago

Specialty Enzymes Market to Surpass USD 10.4 Billion by 2034, Growing at a 6.4% CAGR: Digital Technologies and Automation Drive Efficiency and Cost Reduction | TMR

Growing consumer awareness of enzyme benefits fuels demand for enzyme-based products in various health and wellness sectors. WILMINGTON, Del., July…

5 months ago

OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology

BILLERICA, MA / ACCESSWIRE / July 26, 2024 / OmniGuide Holdings, Inc. (OGH) is thrilled to announce the successful completion…

5 months ago

Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

Southlake, TX, July 26, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the…

5 months ago

Johnson & Johnson Receives Positive CHMP Opinion for Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)

If approved, Yuvanci® would become the only single tablet combination for treatment for patients with PAH Johnson & Johnson’s comprehensive…

5 months ago